Taupitz M, Schnorr J, Wagner S, Kivelitz D, Rogalla P, Claassen G, Dewey M, Robert P, Corot C, Hamm B
Department of Radiology, Charité, Medizinische Fakultät, Humboldt-Universität zu Berlin, Berlin, Germany.
Magn Reson Med. 2001 Nov;46(5):932-8. doi: 10.1002/mrm.1279.
The signal-enhancing characteristics of a new monodisperse monogadolinated macromolecular MR contrast medium (P792) were evaluated for magnetic resonance angiography (MRA) of the coronary arteries. A total of 15 cardiac examinations were performed in pigs at 1.5 T using a 3D gradient-echo sequence. Images were acquired during breath-hold before and up to 35 min after IV injection of Gd-DTPA (0.3 mmol Gd/kg), Gd-BOPTA (0.2 mmol Gd/kg), and P792 (13 micromol Gd/kg). An increase in the signal-to-noise ratio (SNR) of 97% +/- 17%, 108% +/- 37%, and 109% +/- 31% in coronary arteries and of 82% +/- 19%, 82% +/- 24%, and 28% +/- 18% in myocardium, respectively, was measured during the first postcontrast acquisition. The blood-to-myocardium signal-difference-to-noise ratio (SDNR) was significantly higher for P792 than for the other Gd compounds (P <.05) for up to 15 min after injection. Qualitative assessment showed that visualization of the coronary arteries and their branches was significantly better for P792 compared to the low-molecular Gd compounds (P <.05). The blood pool contrast medium P792 is well suited for MRA of the coronary arteries.
对一种新型单分散单钆标记大分子磁共振造影剂(P792)的信号增强特性进行了评估,用于冠状动脉磁共振血管造影(MRA)。在1.5T场强下,使用三维梯度回波序列对猪进行了总共15次心脏检查。在静脉注射钆喷酸葡胺(0.3 mmol钆/千克)、钆贝葡胺(0.2 mmol钆/千克)和P792(13微摩尔钆/千克)之前及注射后长达35分钟的屏气期间采集图像。在首次造影剂注射后的采集过程中,冠状动脉的信噪比(SNR)分别增加了97%±17%、108%±37%和109%±31%,心肌的信噪比分别增加了82%±19%、82%±24%和28%±18%。注射后长达15分钟内,P792的血-心肌信号差异信噪比(SDNR)显著高于其他钆化合物(P<.05)。定性评估显示,与低分子钆化合物相比,P792对冠状动脉及其分支的显示明显更好(P<.05)。血池造影剂P792非常适合冠状动脉MRA。